Latest News for: parkinson’s disease

Edit

Boxing program helps slow down Parkinson’s disease symptoms, one punch at a time

News-Press Now 18 Aug 2025
MIAMI, Florida (WFOR) — About a million people have Parkinson’s disease, according to the Parkinson’s Foundation ... Juan Rodriguez uses boxing to fight an opponent from within, which is Parkinson’s disease.
Edit

Seal Rock Therapeutics Joins The Michael J. Fox Foundation's LITE Program to Advance New Therapies Targeting LRRK2 for Parkinson's Disease

PR Newswire 13 Aug 2025
The LITE program supports the development of new therapies targeting LRRK2 for the treatment of Parkinson's disease patients, including Seal Rock Therapeutics' brain-penetrant LRRK2/ASK1 signaling complex (LASC) inhibitors.
Edit

'No one should endure this journey alone': Parkinson's disease support available

jacksonville.com 12 Aug 2025
A patient who received a new infusion therapy treatment for Parkinson’s disease showed progress after just two days, Sherwood Forest Hospitals said.
Edit

Machine learning helps tailor deep brain stimulation to improve gait in Parkinson’s disease

PsyPost 12 Aug 2025
A team of researchers at the University of California, San Francisco has developed a data-driven method for optimizing deep brain stimulation (DBS) settings that significantly improved walking performance in people with Parkinson’s disease.
Edit

We're partnering with Oxford Mindfulness Foundation (Parkinson's Disease Society of the United Kingdom)

Public Technologies 11 Aug 2025
Parkinson's Disease Society of the United Kingdom published this content on August 11, 2025, and is solely responsible for the information contained herein.
Edit

Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson's Disease

PR Newswire 01 Aug 2025
Energenesis Biomedical plans to submit a Phase II clinical trial application in 2025 to further evaluate the therapeutic efficacy of ENERGI-F705PD in patients with Parkinson's disease ... The Promise of Alpha-Synuclein Targeting in Parkinson's Disease.
Edit

'We don't quit': For those living with Parkinson's disease, giving up not an option

Journal Courier 30 Jul 2025
For people living with Parkinson's disease in west-central Illinois and beyond, letting the neurodegenerative illness beat them simply is not an option ... .
Edit

Parkinson's Disease Drug Market Driven By Cell Therapy & Gene-Based Treatments Datam Intelligence

MENA FN 30 Jul 2025
(MENAFN - EIN Presswire) Parkinson's Disease Therapeutics Market The Parkinson's therapeutics market will grow from USD 5.92 Bn in 2024 to USD 12.83 Bn by 2033 at 8.1% CAGR, driven by novel ... .
Edit

Lords raise our concerns about Universal Credit Bill (Parkinson's Disease Society of the United Kingdom)

Public Technologies 28 Jul 2025
Parkinson's Disease Society of the United Kingdom published this content on July 28, 2025, and is solely responsible for the information contained herein.
Edit

The 10 Year Health Plan for England: what it means for people with Parkinson’s (Parkinson's Disease Society of the United Kingdom)

Public Technologies 25 Jul 2025
Parkinson's Disease Society of the United Kingdom published this content on July 25, 2025, and is solely responsible for the information contained herein.
Edit

Congruence Awarded Grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to Advance Novel GCase Activators and Correctors for Parkinson's Disease with GBA1 Mutations

PR Newswire 24 Jul 2025
In GBA1 Parkinson's disease, GCase deficiency leads to the accumulation of α-synuclein and subsequent death of neuronal cells that are hallmarks of Parkinson's.  The MJFF grant will support the ...
Edit

18 warning signs of Parkinson's disease after Ozzy Osbourne's death at 76

Daily Record 23 Jul 2025
Black Sabbath star Ozzy Osbourne died at 76, five years after he was diagnosed with Parkinson's disease - a condition which has a range of symptoms that people should be aware of ... .
×